Aurinia Pharmaceuticals will delist from the Toronto Stock Exchange. The company made this decision because 94% of Aurinia's daily trading volume over the past 12 months has been on Nasdaq and a dual listing does not justify the cost and administrative effort. The company's last day of trading on the Toronto Stock Exchange will be July 30, 2021.
Aurinia Pharmaceuticals will delist from the Toronto Stock Exchange. The company made this decision because 94% of Aurinia's daily trading volume over the past 12 months has been on Nasdaq and a dual listing does not justify the cost and administrative effort. The company's last day of trading on the Toronto Stock Exchange will be July 30, 2021. 
ir.auriniapharma.com
English (US) 